Literature DB >> 28625784

Heightened sympathetic arousal is demonstrated by skin conductance responsivity to auditory stimuli in a small cohort of neonates with opiate withdrawal.

Christiana N Oji-Mmuo1, Fumiyuki Chin Gardner2, Kim K Doheny3.   

Abstract

To determine the effects of auditory stimulus on skin conductance (SC) in infants with severe neonatal abstinence syndrome (NAS) that required morphine treatment (MT) compared with NAS infants that did not require morphine treatment (non-MT). We prospectively enrolled opiate-exposed term infants without polysubstance exposure. Skin conductance responses to an auditory stimulus (ringing a bell for 3s) near the time of discharge were obtained. Skin conductance was measured before, during, and after the stimulus. Non-parametric tests were used to determine between group and within phase differences. Infants were off MT at the time of SC measurement in response to an auditory stimulus. In a 2-group comparison of MT vs. non-MT infants, there was significantly higher SC responsivity to an auditory stimulus (p <0.05) in the MT group as compared with the non-MT group near discharge. The mean +SE peak morphine dose was 0.85+0.20mg/kg/day in the MT group. The mean Length of Stay (LOS) was 32 vs. 7 (p <0.05) days respectively, for the MT vs. the non-MT group. Our preliminary data suggest that in infants with severe NAS symptoms, higher sympathetic arousal in response to an auditory stimulus persists at discharge, underscoring the need for ongoing evaluation and specialized care at home.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assessment at discharge; Neonatal abstinence syndrome; Objective assessment; Skin conductance; Sympathetic arousal

Mesh:

Substances:

Year:  2017        PMID: 28625784      PMCID: PMC7295008          DOI: 10.1016/j.brainresbull.2017.06.007

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  31 in total

1.  Neonatal abstinence syndrome: Recognition and diagnosis.

Authors:  M M Desmond; G S Wilson
Journal:  Addict Dis       Date:  1975

2.  Neonatal abstinence syndrome: assessment and management.

Authors:  L P Finnegan; J F Connaughton; R E Kron; J P Emich
Journal:  Addict Dis       Date:  1975

3.  Preterm infants' sympathetic arousal and associated behavioral responses to sound stimuli in the neonatal intensive care unit.

Authors:  Arash Salavitabar; Kim Kopenhaver Haidet; Cherie S Adkins; Elizabeth J Susman; Charles Palmer; Hanne Storm
Journal:  Adv Neonatal Care       Date:  2010-06       Impact factor: 1.968

4.  Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.

Authors:  S W Patrick; M M Davis; C U Lehman; W O Cooper
Journal:  J Perinatol       Date:  2015-08       Impact factor: 2.521

5.  Development of central and peripheral catecholaminergic systems in rats addicted perinatally to methadone.

Authors:  C Lau; M Bartolomé; T A Slotkin
Journal:  Neuropharmacology       Date:  1977 Jul-Aug       Impact factor: 5.250

6.  Late presentation of drug withdrawal symptoms in newborns.

Authors:  S R Kandall; L M Gartner
Journal:  Am J Dis Child       Date:  1974-01

7.  Elevated plasma norepinephrine levels in infants of substance-abusing mothers.

Authors:  S L Ward; S Schuetz; L Wachsman; X D Bean; D Bautista; S Buckley; S Sehgal; D Warburton
Journal:  Am J Dis Child       Date:  1991-01

8.  Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience.

Authors:  C Hünseler; M Brückle; B Roth; A Kribs
Journal:  Klin Padiatr       Date:  2013-08-21       Impact factor: 1.349

9.  Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns.

Authors:  Nicola Elisabeth Schubach; Katrin Mehler; Bernhard Roth; Eckhard Korsch; Rainhard Laux; Dominique Singer; Axel von der Wense; András Treszl; Christoph Hünseler
Journal:  Eur J Pediatr       Date:  2016-03-30       Impact factor: 3.183

10.  Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.

Authors:  Lisa Forsberg; Lars Navér; Lars L Gustafsson; Katarina Wide
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

View more
  4 in total

Review 1.  Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.

Authors:  Davida M Schiff; Matthew R Grossman
Journal:  Semin Fetal Neonatal Med       Date:  2019-01-28       Impact factor: 3.926

2.  Prenatal opioid exposure heightens sympathetic arousal and facial expressions of pain/distress in term neonates at 24-48 hours post birth.

Authors:  Christiana N Oji-Mmuo; Rebecca R Speer; Fumiyuki C Gardner; Megan M Marvin; Alexia C Hozella; Kim K Doheny
Journal:  J Matern Fetal Neonatal Med       Date:  2019-04-09

Review 3.  Impact of prenatal opioids on cardiac and autonomic development: systematic review and meta-analysis.

Authors:  Meghan P Howell; Carlie A Wiseman; Maya Z Rosen; Winifred M Yeates; Laura A Wright; Samantha S O'Connell; Benjamin Bhunu; Suttira Intapad; Thomas R Kimball; Stefanie Cheang; Kelly K Gajewski
Journal:  J Perinatol       Date:  2022-07-29       Impact factor: 3.225

4.  Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.

Authors:  Ludmila N Bakhireva; Rajesh C Miranda; Amanda H Mahnke; Melissa H Roberts; Lawrence Leeman; Xingya Ma
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.